Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
We've already indexed 59 COAs attributed to your lab across 2 peptide vendors. Claim this profile and every record links back to you — the canonical source. Free forever.
Auto-generated from public COAs across the corpus. Based in US.
analyticalformulations.comTracking since .
Every reported purity value from Analytical Formulations, Inc., bucketed every 0.5 percentage points. The shape of the distribution is the safety signal — narrow clustering across many COAs is the rubber-stamping fingerprint we flag.
A healthy distribution spreads across multiple bins. A single tall spike (variance under 0.5pp across 10+ COAs) trips the SUSPICIOUSLY_NARROW_VARIANCE flag — see methodology.
What fraction of this lab's COAs report each test type. Real third-party labs typically run a consistent panel; sparse coverage on safety tests (endotoxin, sterility) is a common signal of HPLC-only purity work. Endotoxin is measured against injectable COAs only — raw powders and orals aren't expected to carry it.
| Vendor | Peptide | Lot | Purity | Endo | Tested | |
|---|---|---|---|---|---|---|
| Ion Peptide | KPV | KPV10-02232026 | 99.70% | — | — | View |
| Ion Peptide | 5-Amino-1-MQ | 5AMQ10-02122026 | 99.70% | — | — | View |
| Ion Peptide | KPV | KPV10-02022026 | 99.90% | — | — | View |
Cross-vendor $/mg for peptides Analytical Formulations, Inc. has verified — updated daily.
Analytical Formulations, Inc. has COAs on file for 33 distinct compounds in the Disclosed corpus.
Disclosed Labs has indexed 59 COAs attributed to Analytical Formulations, Inc.. A credibility grade publishes once a statistically sufficient corpus exists.
ISO/IEC 17025 accreditation for Analytical Formulations, Inc. is not confirmed on file at Disclosed Labs. Check the lab's official website or their COA headers directly for the latest accreditation status.
Analytical Formulations, Inc. has tested 33 distinct compounds in the Disclosed Labs corpus, including: Selank, 5-Amino-1-MQ, KPV, ION-2T, ION-3R, GHK-Cu, L-Glutathione, MOTS-c, KLOW 80mg (50:10:10:10), NAD+, and 23 more.
Disclosed Labs has COAs from Analytical Formulations, Inc. attributed to 2 vendors, including: Ion Peptide, Alpha Peptides.
| Ion Peptide | ION-2T | ION2T10-03102026 | 99.70% | ✓ | — | View |
| Ion Peptide | ION-3R | ION3R30-03102026 | 99.70% | — | — | View |
| Alpha Peptides | GHK-Cu | GK-31126328 | 99.60% | — | — | View |
| Alpha Peptides | TB-500 | TB-42326428 | 99.80% | — | — | View |
| Ion Peptide | CJC-1295 + Ipamorelin | — | — | — | — | View |
| Alpha Peptides | BPC-157 | BPC-42326428 | 99.60% | — | — | View |
| Ion Peptide | Selank | SK10-02232026 | 99.50% | — | — | View |
| Ion Peptide | BPC-157 | — | — | — | — | View |
| Ion Peptide | CJC-1295 (no DAC) | — | 99.50% | — | — | View |
| Ion Peptide | MOTS-c | — | 99.50% | — | — | View |
| Ion Peptide | DSIP | DSIP5-02122026 | 99.40% | — | — | View |
| Ion Peptide | Melanotan-II | MLT2-02122026 | 99.50% | — | — | View |
| Ion Peptide | TB-500 | TB510-03102026 | 99.50% | ✓ | — | View |
| Ion Peptide | Semax/Selank | SSB20-03102026 | 99.20% | ✓ | — | View |
| Ion Peptide | Thymalin | THY10-02232026 | 99.20% | — | — | View |
| Ion Peptide | Retatrutide | GP3R20-01272026 | 99.80% | — | — | View |
| Ion Peptide | TB 500 + BPC-157 | — | — | — | — | View |
| Ion Peptide | Melanotan-I | MLT110-02232026 | 99.70% | — | — | View |
| Ion Peptide | ION-2T | ION2T20-03102026 | 99.80% | ✓ | — | View |
| Ion Peptide | BPC-157+TB-500 | — | — | — | — | View |
| Ion Peptide | BPC-157+TB-500 | — | — | — | — | View |
| Alpha Peptides | KPV | KV-31126328 | 99.50% | — | — | View |
| Ion Peptide | GHK-Cu | GU50-03112026 | 99.80% | ✓ | — | View |
| Alpha Peptides | SS-31 | S31-32526328 | 99.50% | — | — | View |
| Alpha Peptides | DSIP | DS-42326428 | 99.20% | — | — | View |
| Alpha Peptides | GLP-2 TZ | T30-32526328 | 99.70% | — | — | View |
| Ion Peptide | GLP-3R | GPR50-02232026 | 99.80% | — | — | View |
| Ion Peptide | SLU-PP-332 | SLP30-02122026 | 99.80% | — | — | View |
| Ion Peptide | KPV | KPV10-03102026 | 99.50% | ✓ | — | View |
| Ion Peptide | GLP-1S | — | 99.80% | — | — | View |
| Alpha Peptides | CJC-1295 (no DAC) | CND-42326428 | 99.50% | — | — | View |
| Ion Peptide | GHRP-2 | GHP25-01272026 | 99.75% | — | — | View |
| Ion Peptide | ION-2T | ION2T40-03102026 | 99.70% | ✓ | — | View |
| Alpha Peptides | MOTS-c | MC10-32526328 | 99.70% | — | — | View |
| Alpha Peptides | Tirzepatide | T60-42326428 | 99.90% | — | 2026-05-01 | View |
| Alpha Peptides | KLOW 80mg (50:10:10:10) | KL-42326428 | 99.80% | — | 2026-05-01 | View |
| Alpha Peptides | Melanotan-II | MT-31126328 | 99.90% | — | 2026-03-30 | View |
| Ion Peptide | GHK-Cu | GUR1G-03102026 | 99.40% | — | 2026-03-18 | View |
| Ion Peptide | GHK-Cu | 0125 | 99.00% | — | 2026-03-18 | View |
| Ion Peptide | Tesamorelin | TESA10-03112026 | 99.60% | ✓ | 2026-03-16 | View |
| Ion Peptide | Melanotan-II | MLT210-03102026 | 99.70% | ✓ | 2026-03-16 | View |
| Ion Peptide | Epithalon | ET10-03102026 | 99.40% | ✓ | 2026-03-16 | View |
| Ion Peptide | IGF-1 LR3 | IGF1-03102026 | 99.60% | ✓ | 2026-03-16 | View |
| Ion Peptide | MOTS-c | MC10-03102026 | 99.60% | ✓ | 2026-03-12 | View |
| Ion Peptide | Melanotan-II | MLT210-02232026 | 99.60% | — | 2026-03-05 | View |
| Ion Peptide | Melanotan-II | MLT210-02242026 | 99.70% | — | 2026-02-24 | View |
| Ion Peptide | Epithalon | ET10-02232026 | 99.40% | — | 2026-02-24 | View |
Disclosed Labs